Mito-extra may be available in the countries listed below.
Ingredient matches for Mito-extra
Mitomycin is reported as an ingredient of Mito-extra in the following countries:
- Germany
International Drug Name Search
Mito-extra may be available in the countries listed below.
Mitomycin is reported as an ingredient of Mito-extra in the following countries:
International Drug Name Search
Supplementing the diet in patients who have or are at risk of developing type 2 diabetes. It should be used along with other treatments for type 2 diabetes. It may also be used for other conditions as determined by your doctor.
Divista is a folic acid, vitamin, omega-3 fatty acid, and mineral combination. It works by lowering blood sugar by making the cells of the body more sensitive to the action of insulin. It also provides vitamins and other supplements to meet nutritional requirements.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Divista. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Divista. Tell your health care provider if you are taking any other medicines, especially any of the following:
Ask your health care provider if Divista may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Divista as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Divista.
All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Divista side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Divista at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Divista out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Divista. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
In some countries, this medicine may only be approved for veterinary use.
Romifidine is reported as an ingredient of Sedivet in the following countries:
Romifidine hydrochloride (a derivative of Romifidine) is reported as an ingredient of Sedivet in the following countries:
International Drug Name Search
ASA MK may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of ASA MK in the following countries:
International Drug Name Search
Pirazinamida may be available in the countries listed below.
Pyrazinamide is reported as an ingredient of Pirazinamida in the following countries:
International Drug Name Search
Fluoropos may be available in the countries listed below.
Fluorometholone is reported as an ingredient of Fluoropos in the following countries:
International Drug Name Search
In the US, Thalidomide (thalidomide systemic) is a member of the following drug classes: leprostatics, miscellaneous antineoplastics, other immunosuppressants and is used to treat Leprosy - Erythema Nodosum Leprosum and Multiple Myeloma.
US matches:
UK matches:
Rec.INN
L04AX02
0000050-35-1
C13-H10-N2-O4
258
Dermatological agent
Immunosuppressant
Antileprotic agent
(RS)-N-(2,6-Dioxo-3-piperidyl)phthalimid (IUPAC)
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
N-(2,6-Dioxo-3-piperidyl)phthalimide (WHO)
α-Phthalimidoglutarimide (WHO)
Phthalimide, N-(2,6-dioxo-3-piperidinyl)-
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
SPC | Summary of Product Characteristics (UK) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Generic Name: acetaminophen and phenyltoloxamine (a seet a MIN oh fen and FEN il toe LOX a meen)
Brand Names: Aceta-Gesic, Acuflex, Alpain, Apagesic, BeFlex, BP Poly-650, Dologesic, Flextra-650, Flextra-DS, Hyflex-650, Hyflex-DS, Lagesic, Major-gesic, Percogesic, Phenagesic, Phenylgesic, Q Flex, Relagesic, RhinoFlex, RhinoFlex 650, Staflex, Vistra, Vitoxapap, Zgesic
Acetaminophen is a pain reliever and a fever reducer.
Phenyltoloxamine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
Acetaminophen and phenyltoloxamine is used to treat runny nose, sneezing, and pain or fever caused by the common cold, flu, or seasonal allergies.
Acetaminophen and phenyltoloxamine may also be used for purposes not listed in this medication guide.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have liver or kidney disease, diabetes, glaucoma, urination problems, an enlarged prostate, heart disease, high blood pressure, a stomach ulcer, or an overactive thyroid.
Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:
kidney disease;
diabetes;
glaucoma;
urination problems;
an enlarged prostate;
heart disease or high blood pressure;
a stomach ulcer; or
an overactive thyroid.
One tablet of this medicine may contain up to 650 mg of acetaminophen. Know the amount of acetaminophen in the specific product you are taking.
Call your doctor if your symptoms do not improve, or if you have a fever for longer than 3 days.
This medication can cause unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.
Since cold or allergy medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
The first signs of an acetaminophen overdose include loss of appetite, nausea, vomiting, stomach pain, sweating, and confusion or weakness. Later symptoms may include pain in your upper stomach, dark urine, and yellowing of your skin or the whites of your eyes.
Overdose symptoms may also include feeling very restless, extreme drowsiness, warmth or tingly feeling, or seizure (convulsions).
fast, pounding, or uneven heartbeat;
confusion, hallucinations, unusual thoughts or behavior;
severe dizziness, anxiety, restless feeling, nervousness;
urinating less than usual or not at all;
nausea, pain in your upper stomach, itching, loss of appetite, dark urine, clay colored stools, jaundice (yellowing of the skin or eyes); or
easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms.
Less serious side effects may include:
dizziness, drowsiness;
blurred vision;
dry mouth, nose, or throat;
mild stomach pain, constipation; or
problems with memory or concentration.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with acetaminophen and phenyltoloxamine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: RhinoFlex side effects (in more detail)
Xyvion may be available in the countries listed below.
Tibolone is reported as an ingredient of Xyvion in the following countries:
International Drug Name Search
Angichromen may be available in the countries listed below.
Trapidil is reported as an ingredient of Angichromen in the following countries:
International Drug Name Search
Noxibel may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Noxibel in the following countries:
International Drug Name Search
am-FET-a-meen a-SPAR-tate, am-FET-a-meen SUL-fate, dex-troe-am-FET-a-meen SAK-a-rate, dex-troe-am-FET-a-meen SUL-fate
Amphetamines have a high potential for abuse, and administration for prolonged periods of time may lead to drug dependence and must be avoided. Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events .
In the U.S.
Available Dosage Forms:
Therapeutic Class: CNS Stimulant
Chemical Class: Amphetamine
Amphetamine and dextroamphetamine combination belongs to the group of medicines called central nervous system (CNS) stimulants. It is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (uncontrollable desire for sleep or sudden attacks of deep sleep) .
Amphetamine and dextroamphetamine combination increases attention and decreases restlessness in patients who are overactive, cannot concentrate for very long or are easily distracted, and have unstable emotions. It is also used as part of a total treatment program that also includes social, educational, and psychological treatment .
Amphetamine and dextroamphetamine combination may also be used for other conditions as determined by your doctor .
amphetamine and dextroamphetamine is available only with a doctor's prescription. Prescriptions cannot be refilled. A new prescription must be obtained from your doctor each time you or your child needs amphetamine and dextroamphetamine .
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For amphetamine and dextroamphetamine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to amphetamine and dextroamphetamine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of amphetamine and dextroamphetamine combination in children with attention-deficit hyperactivity disorder below 3 years of age. Safety and efficacy have not been established .
Appropriate studies on the relationship of age to the effects of amphetamine and dextroamphetamine combination have not been performed in the geriatric population .
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using amphetamine and dextroamphetamine.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking amphetamine and dextroamphetamine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using amphetamine and dextroamphetamine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using amphetamine and dextroamphetamine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using amphetamine and dextroamphetamine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
The presence of other medical problems may affect the use of amphetamine and dextroamphetamine. Make sure you tell your doctor if you have any other medical problems, especially:
Take amphetamine and dextroamphetamine only as directed by your doctor. Do not take more or less of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If too much is taken, it may become habit-forming (causing mental or physical dependence) .
If you think amphetamine and dextroamphetamine is not working properly after you have taken it for several weeks, do not increase the dose. Instead, check with your doctor .
amphetamine and dextroamphetamine should come with a Medication Guide. Read and follow these instructions carefully. Ask your doctor if you have any questions .
Swallow the extended-release capsule whole with water or other liquids. If you cannot swallow the extended-release capsule, you may open it and sprinkle the medicine into a small amount of applesauce. Stir this mixture well and swallow it right away without chewing. Do not store this mixture for future use. Do not crush or chew the medicine inside the capsule .
You may take the extended-release capsule with or without food .
The dose of amphetamine and dextroamphetamine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of amphetamine and dextroamphetamine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of amphetamine and dextroamphetamine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your progress at regular visits to make sure amphetamine and dextroamphetamine is working properly and to check for unwanted effects .
If you will be taking amphetamine and dextroamphetamine in large doses for a long time, do not stop taking it without first checking with your doctor. Your doctor may want you to reduce gradually the amount you are taking before stopping completely .
Do not take amphetamine and dextroamphetamine within 14 days of taking an MAO inhibitor such as Eldepryl®, Marplan®, Nardil®, or Parnate®.
amphetamine and dextroamphetamine may cause some people to feel a false sense of well-being or to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to amphetamine and dextroamphetamine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.
Check with your doctor immediately if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor) .
If you have been using amphetamine and dextroamphetamine for a long time and you think you may have become mentally or physically dependent on it, check with your doctor. Some signs of dependence on amphetamines are:
amphetamine and dextroamphetamine may cause slow growth. If your child is using amphetamine and dextroamphetamine, the doctor will need to keep track of your child's height and weight to make sure that your child is growing properly .
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements .
Before you have any medical tests, tell the medical doctor in charge that you are taking amphetamine and dextroamphetamine. The results of some tests may be affected by amphetamine and dextroamphetamine .
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: amphetamine and dextroamphetamine side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Enalapril / Hydrochloorthiazide Hexal may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril / Hydrochloorthiazide Hexal in the following countries:
Hydrochlorothiazide is reported as an ingredient of Enalapril / Hydrochloorthiazide Hexal in the following countries:
International Drug Name Search
Magnesio Solfato Salf may be available in the countries listed below.
Magnesium Sulfate is reported as an ingredient of Magnesio Solfato Salf in the following countries:
International Drug Name Search
Crafilm may be available in the countries listed below.
Sucralfate is reported as an ingredient of Crafilm in the following countries:
International Drug Name Search
Depnon may be available in the countries listed below.
Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Depnon in the following countries:
International Drug Name Search
Amoxicillina Sandoz may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina Sandoz in the following countries:
International Drug Name Search
Medamol may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Medamol in the following countries:
Paracetamol is reported as an ingredient of Medamol in the following countries:
International Drug Name Search
Generic Name: salsalate (SAL sa late)
Brand Names: Disalcid, Salsitab
Salsalate is a non-steroidal anti-inflammatory drug (NSAID) in a group of drugs called salicylates (sa-LIS-il-ates). This medicine works by reducing substances in the body that cause pain, fever, and inflammation.
Salsalate is used to reduce pain, swelling, and joint stiffness caused by arthritis.
Salsalate may also be used for purposes not listed in this medication guide.
Before taking salsalate, tell your doctor if you have asthma, heart disease, high blood pressure, stomach or intestinal bleeding, diabetes, anemia, a bleeding disorder, liver or kidney disease, nasal polyps, a genetic enzyme deficiency, or if you are dehydrated.
This medicine may cause life-threatening heart or circulation problems such as heart attack or stroke, especially if you use it long term. Do not use salsalate just before or after heart bypass surgery (coronary artery bypass graft, or CABG).
This medicine may also cause serious effects on the stomach or intestines, including bleeding or perforation (forming of a hole). These conditions can be fatal and can occur without warning while you are taking salsalate, especially in older adults.
Salicylates may cause life-threatening heart or circulation problems such as heart attack or stroke, especially if you use it long term. Do not use salsalate just before or after heart bypass surgery (coronary artery bypass graft, or CABG).
Salicylates may also cause serious effects on the stomach or intestines, including bleeding or perforation (forming of a hole). These conditions can be fatal and can occur without warning while you are taking salsalate, especially in older adults.
To make sure you can safely take salsalate, tell your doctor if you have any of these other conditions:
asthma;
heart disease, high blood pressure, congestive heart failure;
a history of stroke or heart attack;
a stomach ulcer or intestinal bleeding;
a bleeding or blood clotting disorder;
diabetes;
swelling or fluid retention;
anemia (a lack of red blood cells);
an enzyme deficiency called glucose-6-phosphate dehydrogenase deficiency (G6PD);
nasal polyps; or
if you are dehydrated.
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Salsalate may be taken up to 3 times per day. Follow your doctor's instructions.
This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using salsalate.
Since salsalate is taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include ringing in your ears, severe dizziness or drowsiness, sweating, fast breathing, severe vomiting or diarrhea, confusion, or seizure (convulsions).
If you are also taking low-dose aspirin because your doctor has prescribed it to prevent heart attack or stroke, do not stop taking it or change your dose without your doctor's advice. Aspirin should be used for cardiovascular conditions only under the supervision of a doctor.
chest pain, severe dizziness, shortness of breath, slurred speech, problems with vision or balance;
sudden numbness or weakness, especially on one side of the body;
feeling like you might pass out;
black, bloody, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
hearing problems, ringing in your ears;
swelling in your hands or feet, rapid weight gain;
fast or pounding heartbeats;
easy bruising or bleeding, fever, chills, sore throat, flu symptoms;
urinating more or less than usual;
severe stomach pain, ongoing nausea or vomiting; or
dark urine, jaundice (yellowing of the skin or eyes).
Less serious side effects may include:
upset stomach, heartburn; or
mild dizziness.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Many drugs can interact with salsalate. Below is just a partial list. Tell your doctor if you are using:
acetazolamide (Diamox);
cyclosporine (Gengraf, Neoral, Sandimmune);
lithium (Eskalith, LithoBid);
methotrexate (Rheumatrex, Trexall);
pemetrexed (Alimta);
tenofovir (Viread);
an antidepressant such as fluoxetine (Prozac) or sertraline (Zoloft);
a blood thinner such as warfarin (Coumadin);
oral diabetes medication;
a diuretic (water pill);
gout medication such as probenecid (Benemid);
heart or blood pressure medication such as atenolol (Tenormin), captopril (Capoten), lisinopril (Prinivil, Zestril), losartan (Cozaar, Hyzaar), metoprolol (Lopressor, Toprol), and others;
medication used to prevent blood clots, such as cilostazol (Pletal) or clopidogrel (Plavix);
osteoporosis medication such as alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel), and others;
sodium bicarbonate, potassium citrate (K-Lyte, Urocit-K), sodium citrate and citric acid (Bicitra, Oracit), or sodium citrate and potassium (Citrolith, Polycitra);
seizure medication such as phenytoin (Dilantin), phenobarbital (Solfoton), valproic acid (Depakene); or
steroid medicine (prednisone and others).
See also: Disalcid side effects (in more detail)
Decreasing the size of the pupil after certain eye examinations or surgery.
Dapiprazole is an antimydriatic. It works by blocking the smooth muscle contraction of the iris, which helps to decrease the size of the pupil.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dapiprazole. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dapiprazole. However, no specific interactions with Dapiprazole are known at this time.
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dapiprazole may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dapiprazole as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dapiprazole.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Headache; light sensitivity; redness and itching of the eyelids; redness or burning when you first put the medicine in your eye.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); swelling of the eyelid.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dapiprazole side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store mixed medicine at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), for 21 days. If Dapiprazole is cloudy or discolored, discard it. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dapiprazole out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dapiprazole. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Fenoximetilpenicilina Fabra may be available in the countries listed below.
Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Fenoximetilpenicilina Fabra in the following countries:
International Drug Name Search
Acenocoumarol Merck may be available in the countries listed below.
Acenocoumarol is reported as an ingredient of Acenocoumarol Merck in the following countries:
International Drug Name Search
Politosse may be available in the countries listed below.
Cloperastine fendizoate (a derivative of Cloperastine) is reported as an ingredient of Politosse in the following countries:
International Drug Name Search
Panfor may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Panfor in the following countries:
International Drug Name Search
Each 5 mL (teaspoonful) contains:
Dexamethasone, USP 0.5 mg
Also contains:
Benzoic Acid, USP 0.1%
(as preservative)
Alcohol 5.1%
Inactive Ingredients: Artificial Raspberry Flavor; Citric Acid, USP; FD&C Red No. 40; Liquid Sugar; Propylene Glycol, USP and Purified Water, USP. It may also contain Sodium Citrate, USP.
Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract.
Dexamethasone, a synthetic adrenocortical steroid, is a white to practically white, odorless, crystalline powder. It is stable in air. It is practically insoluble in water. The molecular weight is 392.47. It is designated chemically as 9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione. The molecular formula is C22H29FO5 and the structural formula is:
Naturally occurring glucocorticoids, (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs, including dexamethasone, are primarily used for their potent antiinflammatory effects in disorders of many organ systems.
Glucocorticoids cause profound and varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli.
At equipotent anti-inflammatory doses, dexamethasone almost completely lacks the sodium-retaining property of hydrocortisone and closely related derivatives of hydrocortisone.
In patients on corticosteroid therapy subjected to unusual stress, increased dosage of rapidly acting corticosteroids before, during, and after the stressful situation is indicated.
Drug-induced secondary adrenocortical insufficiency may result from too rapid withdrawal of corticosteroids and may be minimized by gradual reduction of dosage. This type of relative insufficiency may persist for months after discontinuation of therapy; therefore, in any situation of stress occurring during that period, hormone therapy should be reinstituted. If the patient is receiving steroids already, dosage may have to be increased. Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently.
Corticosteroids may mask some signs of infection, and new infections may appear during their use. There may be decreased resistance and inability to localize infection when corticosteroids are used. Moreover, corticosteroids may affect the nitroblue-tetrazolium test for bacterial infection and produce false-negative results.
In cerebral malaria, a double-blind trial has shown that the use of corticosteroids is associated with prolongation of coma and a higher incidence of pneumonia and gastrointestinal bleeding.
Corticosteroids may activate latent amebiasis. Therefore, it is recommended that latent or active amebiasis be ruled out before initiating corticosteroid therapy in any patient who has spent time in the tropics or any patient with unexplained diarrhea.
Prolonged use of corticosteroids may produce posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, and may enhance the establishment of secondary ocular infections due to fungi or viruses.
Since adequate human reproduction studies have not been done with corticosteroids, use of these drugs in pregnancy or in women of childbearing potential requires that the anticipated benefits be weighed against the possible hazards to the mother and embryo or fetus. Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism.
Corticosteroids appear in breast milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other unwanted effects. Mothers taking pharmacologic doses of corticosteroids should be advised not to nurse.
Average and large doses of hydrocortisone or cortisone can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium. These effects are less likely to occur with the synthetic derivatives except when used in large doses. Dietary salt restriction and potassium supplementation may be necessary. All corticosteroids increase calcium excretion.
Administration of live virus vaccines, including smallpox, is contraindicated in individuals receiving immunosuppressive doses of corticosteroids. If inactivated viral or bacterial vaccines are administered to individuals receiving immunosuppressive doses of corticosteroids, the expected serum antibody response may not be obtained. However, immunization procedures may be undertaken in patients who are receiving corticosteroids as replacement therapy, e.g., for Addison's disease.
Persons who are on drugs which suppress the immune system are more susceptible to infections than healthy individuals. Chickenpox and measles, for example, can have more serious or even fatal course in non-immune children or adults on corticosteroids. In such children or adults who have not had these diseases, particular care should be taken to avoid exposure. How the dose, route and duration of corticosteroid administration affects the risk of developing a disseminated infection is not known. The contribution of the underlying disease and/or prior corticosteroid treatment to the risk is also not known. If exposed to chickenpox, prophylaxis with varicella zoster immune globulin (VZlG) may be indicated. If exposed to measles, prophylaxis with pooled intramuscular immunoglobulin (IG) may be indicated. (See the respective package inserts for complete VZIG and IG prescribing information.) If chickenpox develops, treatment with antiviral agents may be considered.
The use of Dexamethasone Elixir in active tuberculosis should be restricted to those cases of fulminating or disseminated tuberculosis in which the corticosteroid is used for the management of the disease in conjunction with an appropriate antituberculous regimen.
If corticosteroids are indicated in patients with latent tuberculosis or tuberculin reactivity, close observation is necessary as reactivation of the disease may occur. During prolonged corticosteroid therapy, these patients should receive chemoprophylaxis.
Literature reports suggest an apparent association between use of corticosteroids and left ventricular free wall rupture after a recent myocardial infarction; therefore, therapy with corticosteroids should be used with great caution in these patients.
Following prolonged therapy, withdrawal of corticosteroids may result in symptoms of the corticosteroid withdrawal syndrome including fever, myalgia, arthralgia, and malaise. This may occur in patients even without evidence of adrenal insufficiency.
There is an enhanced effect of corticosteroids in patients with hypothyroidism and in those with cirrhosis.
Corticosteroids should be used cautiously in patients with ocular herpes simplex because of possible corneal perforation.
The lowest possible dose of corticosteroid should be used to control the condition under treatment, and when reduction in dosage is possible, the reduction should be gradual.
Psychic derangements may appear when corticosteroids are used, ranging from euphoria, insomnia, mood swings, personality changes, and severe depression, to frank psychotic manifestations. Also, existing emotional instability or psychotic tendencies may be aggravated by corticosteroids.
Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia.
Steroids should be used with caution in nonspecific ulcerative colitis, if there is a probability of impending perforation, abscess, or other pyogenic infection, diverticulitis, fresh intestinal anastomoses, active or latent peptic ulcer, renal insufficiency, hypertension, osteoporosis and myasthenia gravis. Fat embolism has been reported as a possible complication of hypercortisonism.
When large doses are given, some authorities advise that corticosteroids be taken with meals and antacids taken between meals to help to prevent peptic ulcer.
Growth and development of infants and children on prolonged corticosteroid therapy should be carefully observed.
Steroids may increase or decrease motility and number of spermatozoa in some patients.
Phenytoin, phenobarbital, ephedrine, and rifampin may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring adjustment in corticosteroid dosage. These interactions may interfere with dexamethasone suppression tests which should be interpreted with caution during administration of these drugs.
False-negative results in the dexamethasone suppression test (DST) in patients being treated with indomethacin have been reported. Thus, results of the DST should be interpreted with caution in these patients.
The prothrombin time should be checked frequently in patients who are receiving corticosteroids and coumarin anticoagulants at the same time because of reports that corticosteroids have altered the response to these anticoagulants. Studies have shown that the usual effect produced by adding corticosteroids is inhibition of response to coumarins, although there have been some conflicting reports of potentiation not substantiated by studies.
When corticosteroids are administered concomitantly with potassium-depleting diuretics, patients should be observed closely for development of hypokalemia.
Persons who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles. Patients should also be advised that if they are exposed, medical advice should be sought without delay.
Fluid and Electrolyte Disturbances:
Musculoskeletal:
Gastrointestinal:
Dermatologic:
Neurologic:
Endocrine:
Ophthalmic:
Metabolic:
Cardiovascular:
Other:
Reports of acute toxicity and/or death following overdosage of glucocorticoids are rare. In the event of overdosage, no specific antidote is available; treatment is supportive and symptomatic.
The oral LD50 of dexamethasone in female mice was 6.5 g/kg.
For oral administration: DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE AND THE RESPONSE OF THE PATIENT.
The initial dosage varies from 0.75 to 9 mg a day depending on the disease being treated. In less severe diseases doses lower than 0.75 mg may suffice, while in severe diseases doses higher than 9 mg may be required. The initial dosage should be maintained or adjusted until the patient's response is satisfactory. If satisfactory clinical response does not occur after a reasonable period of time, discontinue Dexamethasone Elixir and transfer the patient to other therapy.
After a favorable initial response, the proper maintenance dosage should be determined by decreasing the initial dosage in small amounts to the lowest dosage that maintains an adequate clinical response.
Patients should be observed closely for signs that might require dosage adjustment, including changes in clinical status resulting from remissions or exacerbations of the disease, individual drug responsiveness, and the effect of stress (e.g., surgery, infection, trauma). During stress it may be necessary to increase dosage temporarily.
If the drug is to be stopped after more than a few days of treatment, it usually should be withdrawn gradually.
The following milligram equivalents facilitate changing to Dexamethasone Elixir from other glucocorticoids:
Dexamethasone Elixir | METHYLPREDNI-SOLONE AND TRIAMCINOLONE | PREDNISOLONE AND PREDNISONE | HYDROCORTISONE | CORTISONE |
---|---|---|---|---|
0.75 mg = | 4 mg = | 5 mg = | 20 mg = | 25 mg |
Dexamethasone Elixir 0.5 mg/5 mL is supplied as a clear, red, raspberry-flavored liquid in the following sizes:
100 mL fill in a 4 fl oz bottle with separately packaged dropper assembly. Dropper graduated for 0.125 mg and 0.25 mg.
8 fl oz (No Dropper) (237 mL)
Store at controlled room temperature, 15 °–30 °C (59 °–86 °F).
KEEP TIGHTLY CLOSED
AVOID FREEZING
Dispense in a tight container as defined in the USP.
Rx Only
Product No.: 8466
Manufactured By: Morton Grove Pharmaceuticals, Inc.
Morton Grove, IL 60053
A50-8466-08 REV. 04-08
MGP
NDC 60432-466-08
DEXAMETHASONE
ELIXIR, USP
0.5 mg/5 mL
DO NOT USE IF TAMPER-EVIDENT
SEAL IS BROKEN OR MISSING.
Rx Only
NET: 8 fl oz (237 mL)
DEXAMETHASONE dexamethasone elixir | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA088254 | 07/27/1983 |
Labeler - Morton Grove Pharmaceuticals, Inc. (801897505) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pharmacia and Upjohn Company | 829076566 | API MANUFACTURE |